Hansa Biopharma AB (publ) (LON:0RC7)

Hansa Biopharma AB Revenue

In the year 2025, Hansa Biopharma AB had annual revenue of 222.27M SEK with 29.74% growth. Hansa Biopharma AB had revenue of 75.99M in the quarter ending December 31, 2025, with 134.99% growth.

• Revenue: 222.27M SEK
• Revenue Growth: +29.74%
• P/S Ratio: 19.13
• Revenue / Employee: 1.67M SEK
• Employees: 133
• Market Cap: 342.68M GBP

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	222.27M	50.95M	29.74%
Dec 31, 2024	171.32M	37.22M	27.76%
Dec 31, 2023	134.09M	-20.43M	-13.22%
Dec 31, 2022	154.53M	120.65M	356.12%
Dec 31, 2021	33.88M	27.78M	455.56%